This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Elizabeth M. Bruckheimer: Innovating Cancer Therapy Through Gene Delivery
Introduction
Elizabeth M. Bruckheimer is an accomplished inventor based in Houston, Texas, with a strong focus on advancements in cancer treatment through innovative gene therapy techniques. With her groundbreaking work, she has made significant contributions to the field of medical research.
Latest Patents
Bruckheimer holds a patent titled "Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery." This invention primarily involves the use of viral vectors as expression systems to transform human cells, both in vitro and in vivo. Specifically, it utilizes adenoviral vectors that contain pro-apoptotic genes, showcasing their potential applications in cancer therapy.
Career Highlights
Elizabeth Bruckheimer is currently affiliated with the University of Texas System. Her role there allows her to combine research with practical applications, leading to advancements that could change the landscape of cancer treatments.
Collaborations
Throughout her career, Bruckheimer has collaborated with notable colleagues such as Timothy J. McDonnell and Stephen G. Swisher. These partnerships have been vital in enhancing her research and expanding the impact of her inventions.
Conclusion
With her innovative patent and collaborations, Elizabeth M. Bruckheimer exemplifies the spirit of invention in the biomedical field. Her work at the University of Texas System continues to pave the way for new cancer therapies, demonstrating the vital role that inventors play in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
